niraparib
immunitybio,gsk,janssen
['nmibc', 'magnitude', 'bladder', 'mibc', 'immunitybio']
immunitybio announces over 24 months median duration of complete remission, with 100% nmibc cis patient survival, setting a new magnitude of benefit in patients with bcg unresponsive bladder cancer 
OrganaBio is on a mission to transform a world of research into a world of cell therapies.